21648208

Source:http://linkedlifedata.com/resource/pubmed/id/21648208

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0014653, umls-concept:C0205160, umls-concept:C0966225, umls-concept:C1960048
pubmed:issue	115
pubmed:dateCreated	2011-6-8
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9439295
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anti-Idiotypic, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/omalizumab
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1167-7422
pubmed:issnType	Print
pubmed:volume	20
pubmed:owner	NLM
pubmed:pagination	92
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21648208-Anti-Asthmatic Agents, pubmed-meshheading:21648208-Antibodies, Anti-Idiotypic, pubmed-meshheading:21648208-Antibodies, Monoclonal, pubmed-meshheading:21648208-Antibodies, Monoclonal, Humanized, pubmed-meshheading:21648208-Asthma, pubmed-meshheading:21648208-Child, pubmed-meshheading:21648208-Humans, pubmed-meshheading:21648208-Severity of Illness Index, pubmed-meshheading:21648208-Time Factors
pubmed:year	2011
pubmed:articleTitle	Omalizumab in children: a negative risk-benefit balance in severe persistent asthma.
pubmed:publicationType	Journal Article